State Of Wyoming Alkermes Plc. Transaction History

State Of Wyoming

$778 Million
Q2 2025

A detailed history of State Of Wyoming transactions in Alkermes Plc. stock. As of the latest transaction made, State Of Wyoming holds 18,677 shares of ALKS stock, worth $578,800. This represents 0.07% of its overall portfolio holdings.

Number of Shares

18,677

Previous 11,114 68.05%

Holding current value

$578,800

Previous $366,000 45.9%

% of portfolio

0.07%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 19, 2025	BUY	$26.59 - $32.65 $201,100 - $246,931	7,563 Added 68.05%	18,677 $534,000
Q1 2025 May 14, 2025	BUY	$28.08 - $36.0 $117,346 - $150,444	4,179 Added 60.26%	11,114 $366,000
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $5,731 - $7,015	223 Added 3.32%	6,935 $199,000
Q3 2024 Nov 14, 2024	SELL	$23.01 - $28.55 $28,877 - $35,830	-1,255 Reduced 15.75%	6,712 $187,000
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $32,145 - $37,727	1,385 Added 21.04%	7,967 $192,000
Q1 2024 May 13, 2024	SELL	$26.4 - $32.56 $77,880 - $96,052	-2,950 Reduced 30.95%	6,582 $178,000
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $222,762 - $273,377	9,532 New	9,532 $264,000
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $96,821 - $115,797	4,413 New	4,413 $115,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $59,136 - $68,409	-2,240 Reduced 31.87%	4,789 $143,000
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $16,149 - $19,593	700 Added 11.06%	7,029 $186,000
Q4 2021 Feb 11, 2022	BUY	$21.47 - $32.08 $59,987 - $89,631	2,794 Added 79.04%	6,329 $148,000
Q3 2021 Feb 11, 2022	BUY	$23.37 - $32.13 $49,637 - $68,244	2,124 Added 150.53%	3,535 $109,000
Q2 2021 Feb 11, 2022	BUY	$18.78 - $25.15 $25,353 - $33,952	1,350 Added 2213.11%	1,411 $35,000
Q1 2021 Feb 08, 2022	BUY	$18.21 - $23.2 $1,110 - $1,415	61 New	61 $1,000

Others Institutions Holding ALKS

# of Institutions

395

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.09B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account